letrozole has been researched along with Deficiency of Glucose-6-Phosphate Dehydrogenase in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Breast cancer is the leading cause of neoplasia-related deaths among women, but no data are available in the literature on the safe use of oncological treatments in glucose 6-phosphate dehydrogenase (G6PD)-deficient patients." | 1.38 | Safe chemotherapy and hormone therapy for treating early breast cancer in a glucose 6-phosphate dehydrogenase-deficient patient: case report. ( Bramati, A; Farina, G; Girelli, S; La Verde, N; Mihali, D; Moretti, A; Piva, S; Sburlati, P, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| La Verde, N | 1 |
| Bramati, A | 1 |
| Girelli, S | 1 |
| Piva, S | 1 |
| Moretti, A | 1 |
| Sburlati, P | 1 |
| Mihali, D | 1 |
| Farina, G | 1 |
1 other study available for letrozole and Deficiency of Glucose-6-Phosphate Dehydrogenase
| Article | Year |
|---|---|
Safe chemotherapy and hormone therapy for treating early breast cancer in a glucose 6-phosphate dehydrogenase-deficient patient: case report.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherap | 2012 |